AI in Life Science Market by Offering, Application, Tool, End User - Global Forecast to 2031

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders

2.1 Key Insights and Market Highlights
2.2 Key Market Participants: Share Insights and Strategic Developments
2.3 Disruptive Trends Shaping the Market
2.4 High-Growth Segments & Emerging Frontiers
2.5 Snapshot: Global Market Size, Growth Rate, and Forecast

3.1 AI in Life Science Market Overview
3.2 AI in Life Science Market, by Application & Region
3.3 AI in Life Science Market: Regional Snapshot

4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Surging Demand for Accelerated Drug Discovery and R&D Pipeline Optimization
4.2.1.2 Growing Cross-Industry Partnerships
4.2.1.3 Expanding Applications of AI in Clinical Trial Design, Patient Recruitment, and Operational Efficiency
4.2.1.4 Growing Availability of Large-Scale Biomedical Datasets and Advances in Computing Infrastructure
4.2.1.5 Supportive Government Policies, Funding Initiatives, and Regulatory Frameworks
4.2.2 Restraints
4.2.2.1 Data Privacy and Cybersecurity Concerns
4.2.2.2 Algorithmic Bias and Clinician Trust Deficits
4.2.2.3 High Implementation Costs, Technical Complexity, and Integration Challenges With Legacy It Systems
4.2.3 Opportunities
4.2.3.1 Generative AI and Foundation Models for De Novo Drug Design
4.2.3.2 Rising Focus on Rare Disease Treatments
4.2.3.3 Growing Demand for Precision and Personalized Medicine
4.2.3.4 AI Integration in Academic Research Institutes and Government-Backed Biomedical Innovation Programs
4.2.4 Challenges
4.2.4.1 Low Data Fragmentation, Interoperability Deficits
4.2.4.2 Talent Scarcity and Organizational Readiness
4.3 Unmet Needs and White Spaces
4.4 Interconnected Markets and Cross-Sector Opportunities
4.5 Strategic Moves by Tier-1/2/3 Players

5.1 Porter’S Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of Substitutes
5.1.4 Threat of New Entrants
5.1.5 Intensity of Competitive Rivalry
5.2 Macroeconomic Indicators
5.2.1 Introduction
5.2.2 GDP Trends and Forecast
5.2.3 Trends in Global Healthcare It Industry
5.3 Value Chain Analysis
5.4 Ecosystem Analysis
5.5 Pricing Analysis
5.5.1 Indicative Price for AI in Life Science Market (2025)
5.5.2 Indicative Price for AI in Life Science Market, by Region (2025)
5.6 Key Conferences and Events, 2026-2027
5.7 Trends/Disruptions Impacting Customer Business
5.8 Investment and Funding Scenario
5.9 Case Study Analysis
5.10 Impact of 2025 US Tariff - AI in Life Science Market
5.10.1 Introduction
5.10.2 Key Tariff Rates
5.10.3 Price Impact Analysis
5.10.4 Impact on Country/Region
5.10.4.1 US
5.10.4.2 Europe
5.10.4.3 Asia-Pacific
5.10.5 Impact on End Users
5.10.5.1 Cro & Cdmo
5.10.5.2 Pharmaceutical & Biotechnology Companies
5.10.5.3 Research Centers & Academic Institutes
5.10.5.4 Diagnostic Companies

6.1 Regional Regulations and Compliance
6.1.1 Regulatory Bodies, Government Agencies, and Other Organizations
6.1.2 North America
6.1.3 Europe
6.1.4 Asia-Pacific
6.1.5 Middle East & Africa
6.1.6 Latin America
6.1.7 Industry Standards

7.1 Key Emerging Technologies
7.1.1 Graph Neural Networks
7.1.2 Computer Vision
7.1.3 Predictive Analytics
7.2 Complementary Technologies
7.2.1 Next-Generation Sequencing
7.2.2 Real-World Evidence/Real-World Data
7.2.3 Personalization Engines
7.3 Adjacent Technologies
7.3.1 Cloud Computing
7.3.2 Blockchain
7.3.3 Big Data & Advanced Analytics
7.4 Technology/Product Roadmap
7.5 Patent Analysis
7.5.1 Insights: Jurisdiction and Top Applicant Analysis
7.6 Future Applications
7.6.1 AI-Driven Drug Discovery
7.6.2 Genomic Analysis
7.6.3 Precision Medicine
7.6.4 Virtual Drug Screening

8.1 Introduction
8.2 Decision-Making Process
8.3 Buyer Stakeholders and Buying Evaluation Criteria
8.3.1 Key Stakeholders in Buying Process
8.3.2 Buying Criteria
8.4 Adoption Barriers & Internal Challenges
8.5 Unmet Needs From Various End-Use Industries
8.5.1 Unmet Needs
8.5.2 End User Expectations
8.6 Market Profitability

9.1 Introduction
9.2 Machine Learning
9.2.1 Deep Learning
9.2.1.1 Convolutional Neural Networks
9.2.1.1.1 High-Sensitivity Medical Imaging AI Across Oncology and Radiology Pathways - Key Driver
9.2.1.2 Recurrent Neural Networks
9.2.1.2.1 Sequential Biological Data Processing Drives Adoption in Clinical and Genomic Applications
9.2.1.3 Generative Adversarial Networks
9.2.1.3.1 Synthetic Data Generation to Overcome Life Science Data Scarcity Barriers Boosts Adoption
9.2.1.4 Graph Neural Networks
9.2.1.4.1 Graph AI Architectures Modeling Molecular Interactions to Advance Target and Pathway Discovery
9.2.1.5 Others
9.2.1.5.1 Transformer and Diffusion Architectures Expanding Deep Learning Frontiers in Life Sciences
9.2.2 Supervised Learning
9.2.2.1 Segment Driven by Accurate Prediction of Compound Potency and Selectivity Across Diverse Chemical Series
9.2.3 Reinforcement Learning
9.2.3.1 Optimized Drug Dosing, Trial Design, and Autonomous Laboratory Systems to Drive Segment
9.2.4 Unsupervised Learning
9.2.4.1 Unsupervised AI Revealing Hidden Biological Patterns Within High-Dimensional Omics Datasets
9.2.5 Other Machine Learning Technologies
9.2.5.1 Semi-Supervised and Federated Learning Overcome Data Scarcity and Privacy Constraints
9.3 Natural Language Processing
9.3.1 Biomedical Llms and Clinical Nlp Automating Knowledge Extraction From Unstructured Health Data
9.4 Context-Aware Processing and Computing
9.4.1 Segment Driven by Dynamic, Patient-Specific Insights Across Clinical Workflows
9.5 Computer Vision
9.5.1 Transformation of Pathology, Dermatology, and Drug Manufacturing Inspection Processes - Key Drivers
9.6 Image Analysis
9.6.1 Accelerated Digital Pathology, Lab Imaging, and Document Processing to Boost Adoption
9.7 Other Tools

10.1 Introduction
10.2 Clinical Applications
10.2.1 Reduced Development Timelines and Improved Clinical Success to Drive Segment
10.2.2 Drug Discovery
10.2.2.1 AI-Driven Target Identification Transforming Biopharma R&D Productivity and Success Rates
10.2.3 Medical Imaging & Diagnostics
10.2.3.1 Accelerating Fda Clearances and Radiology Digitization Drives Clinical AI Imaging Adoption
10.2.4 Clinical Trials
10.2.4.1 AI-Powered Trial Optimization and Decentralized Models Accelerating Patient-Centric Research
10.2.5 Precision Medicine
10.2.5.1 Multi-Omics AI Integration Enabling Individualized Therapy Selection At Population Scale
10.2.6 Other Clinical Applications
10.2.6.1 AI-Augmented Clinical Decision Support Expanding Into Pharmacovigilance and Rare Disease
10.3 Non-Clinical Applications
10.3.1 R&D Support
10.3.1.1 AI-Enabled Literature Mining and Lab Automation Multiplying R&D Throughput Significantly
10.3.2 Data Analytics & Reporting
10.3.2.1 Real-World Evidence and AI Analytics Transforming Strategic Decision-Making Across Organizations
10.3.3 Manufacturing & Quality Assurance
10.3.3.1 Predictive Quality AI and Continuous Manufacturing Reduce Batch Failures and Compliance Risk
10.3.4 Regulatory Affairs
10.3.4.1 Fda and Ema AI Guidance Catalyzing Regulatory Submission Automation and Pharmacovigilance Efficiency

11.1 Introduction
11.2 Software
11.2.1 AI Software Platforms Becoming Core Infrastructure for Life Science Digital Transformation
11.3 Service
11.3.1 Specialized AI Services Bridging Validation and Compliance Gaps Across Life Science Enterprises

12.1 Introduction
12.2 Cloud-Based Solutions
12.2.1 Hyperscale Cloud Infrastructure Accelerates Life Science AI Scalability and Collaborative Research
12.3 on-Premise Solutions
12.3.1 Data Sovereignty and Gxp Compliance Sustain on-Premise AI Deployment Across Regulated Environments
12.4 Hybrid Solutions
12.4.1 Hybrid Architectures Balance Regulatory Compliance, Data Security, and AI Scalability Demands

13.1 Introduction
13.2 Cro & Cdmo
13.2.1 AI-Powered Cros & Cdmos Compete on Speed, Quality, and Data Intelligence Differentiation
13.3 Pharmaceutical Companies
13.3.1 AI Embedded Across Discovery, Trials, and Commercial Operations Broadly by Pharma Leaders
13.4 Biotechnology Companies
13.4.1 AI-Native Biotech Models Compressing Drug Discovery Timelines From Years to Months
13.5 Diagnostic Companies
13.5.1 AI-Augmented Diagnostics Elevate Sensitivity and Throughput Across Molecular and Imaging Platforms
13.6 Academic & Government Laboratories
13.6.1 Public AI Research Programs and Open Science Initiatives Build Foundational Life Science Infrastructure
13.7 Other End Users

14.1 Introduction
14.2 End-to-End Solution
14.2.1 Integrated AI Platforms Compressing Drug Development Timelines Across Entire Value Chains
14.3 Niche/Point Solutions
14.3.1 Disease-Specific AI Tools Deliver Measurable Outcomes in Targeted Research Workflows
14.4 AI Technology
14.4.1 Foundation Models and Generative AI Redefine Core Scientific Discovery Capabilities
14.5 Services
14.5.1 Professional AI Services Enable Compliant Deployment Across Regulated Life Science Environments

15.1 Introduction
15.2 North America
15.2.1 Macroeconomic Outlook for North America
15.2.2 US
15.2.2.1 Record Fda Approvals and Federal Funding Propel AI Medical Device Commercialization
15.2.3 Canada
15.2.3.1 Federal AI Investment and Sovereign Compute Strategy Catalyze Life Sciences Innovation
15.3 Europe
15.3.1 Macroeconomic Outlook for Europe
15.3.2 Germany
15.3.2.1 Prescription Digital Health App Framework Propels Market
15.3.3 France
15.3.3.1 National AI-Health Data Strategy and Health Data Hub Anchor Data-Driven Life Sciences
15.3.4 UK
15.3.4.1 Nhs Ten-Year Plan Positions AI as Core Infrastructure for National Care Transformation
15.3.5 Italy
15.3.5.1 National Recovery Plan Digitization Funding Opens New Hospital AI Adoption Pathways
15.3.6 Spain
15.3.6.1 National AI Strategy and Sns Digitization Align Life Sciences Sector With EU AI Ambitions
15.3.7 Rest of Europe
15.4 Asia-Pacific
15.4.1 Macroeconomic Outlook for Asia-Pacific
15.4.2 China
15.4.2.1 Nmpa High-End Device Policy and AI Standardization Body Streamline AI Commercialization
15.4.3 Japan
15.4.3.1 Pmda Adaptive AI Framework and Medical Dx Reforms Accelerate Samd Commercialization
15.4.4 India
15.4.4.1 Indiaai Mission and National Health Data Infrastructure Enable Population-Scale AI Deployment
15.4.5 Australia
15.4.5.1 My Health Record Ecosystem and Tga Samd Pathways Underpin AI-Ready Digital Infrastructure
15.4.6 South Korea
15.4.6.1 K-Medtech Ecosystem and Mfds AI Regulatory Guidance Propel Smart Hospital AI Adoption
15.4.7 Rest of Asia-Pacific
15.5 Latin America
15.5.1 Macroeconomic Outlook for Latin America
15.5.2 Brazil
15.5.2.1 Rnds National Health Network Provides Digital Backbone for AI Healthcare Integration
15.5.3 Mexico
15.5.3.1 Imss Digital Transformation and National AI Strategy Drive AI Integration Into Public Healthcare
15.5.4 Rest of Latin America
15.6 Middle East & Africa
15.6.1 Macroeconomic Outlook for Middle East & Africa
15.6.2 GCC
15.6.3 Saudi Arabia
15.6.3.1 Vision 2030 Health Sector Transformation Program Drives AI-Enabled Care Delivery At Scale
15.6.4 UAE
15.6.4.1 Malaffi, Nabidh Interoperability and Emirati Genome Programme Establish AI-Ready Data Foundation
15.6.5 Rest of GCC
15.6.5.1 Rising Demand for Telehealth & Virtual Care to Propel Market
15.6.6 South Africa
15.6.6.1 National Health Insurance Framework and Digital Health Programs Catalyze AI Market Entry
15.6.7 Rest of Middle East & Africa

16.1 Overview
16.2 Key Player Strategies/Right to Win
16.2.1 Overview of Strategies Adopted by Key Players in AI in Life Science Market
16.3 Revenue Analysis
16.4 Market Share Analysis, 2025
16.5 Company Evaluation Matrix: Key Players, 2025
16.5.1 Stars
16.5.2 Emerging Leaders
16.5.3 Pervasive Players
16.5.4 Participants
16.5.5 Company Footprint: Key Players, 2025
16.5.5.1 Company Footprint
16.5.5.2 Region Footprint
16.5.5.3 Offering Footprint
16.5.5.4 Application Footprint
16.5.5.5 End User Footprint
16.5.5.6 Tools Footprint
16.6 Company Evaluation Matrix: Startups/SMEs, 2025
16.6.1 Progressive Companies
16.6.2 Responsive Companies
16.6.3 Dynamic Companies
16.6.4 Starting Blocks
16.6.5 Competitive Benchmarking: Startups/SMEs, 2025
16.6.5.1 Detailed List of Key Startups/SMEs
16.6.5.2 Competitive Benchmarking of Startups/SMEs
16.7 Valuation & Financial Metrics
16.7.1 Financial Metrics
16.7.2 Company Valuation
16.8 Brand/Software Comparison
16.9 Competitive Scenario
16.9.1 Product/Service Launches & Approvals
16.9.2 Deals
16.9.3 Expansions

17.1 Key Players
17.1.1 Nvidia Corporation
17.1.1.1 Business Overview
17.1.1.2 Products/Solutions Offered
17.1.1.3 Recent Developments
17.1.1.3.1 Product Launches & Enhancements
17.1.1.3.2 Deals
17.1.1.3.3 Other Developments
17.1.1.4 The Analyst's View
17.1.1.4.1 Key Strengths
17.1.1.4.2 Strategic Choices
17.1.1.4.3 Weaknesses and Competitive Threats
17.1.2 Illumina, Inc.
17.1.2.1 Business Overview
17.1.2.2 Products/Solutions Offered
17.1.2.3 Recent Developments
17.1.2.3.1 Product Launches & Enhancements
17.1.2.3.2 Deals
17.1.2.4 The Analyst's View
17.1.2.4.1 Key Strengths
17.1.2.4.2 Strategic Choices
17.1.2.4.3 Weaknesses and Competitive Threats
17.1.3 Tempus AI, Inc.
17.1.3.1 Business Overview
17.1.3.2 Products Offered
17.1.3.3 Recent Developments
17.1.3.3.1 Deals
17.1.3.3.2 Other Developments
17.1.4 Recursion
17.1.4.1 Business Overview
17.1.4.2 Products/Solutions Offered
17.1.4.3 Recent Developments
17.1.4.3.1 Product Launches & Enhancements
17.1.4.3.2 Deals
17.1.4.3.3 Expansions
17.1.4.4 The Analyst's View
17.1.4.4.1 Key Strengths
17.1.4.4.2 Strategic Choices
17.1.4.4.3 Weaknesses and Competitive Threats
17.1.5 Dassault Systèmes SE
17.1.5.1 Business Overview
17.1.5.2 Products Offered
17.1.5.3 Recent Developments
17.1.5.3.1 Product Launches & Enhancements
17.1.5.3.2 Deals
17.1.5.3.3 Other Developments
17.1.6 Schrödinger, Inc.
17.1.6.1 Business Overview
17.1.6.2 Products/Solutions Offered
17.1.6.3 Recent Developments
17.1.6.3.1 Deals
17.1.6.3.2 Other Developments
17.1.7 Data4Cure, Inc.
17.1.7.1 Business Overview
17.1.7.2 Products Offered
17.1.7.3 Recent Developments
17.1.7.3.1 Product Launches & Enhancements
17.1.7.3.2 Other Developments
17.1.8 Microsoft Corporation
17.1.8.1 Business Overview
17.1.8.2 Products Offered
17.1.8.3 Recent Developments
17.1.8.3.1 Product Launches & Enhancements
17.1.8.3.2 Deals
17.1.8.3.3 Other Developments
17.1.9 Insilico Medicine
17.1.9.1 Business Overview
17.1.9.2 Products/Services Offered
17.1.9.3 Recent Developments
17.1.9.3.1 Product Launches & Enhancements
17.1.9.3.2 Deals
17.1.9.3.3 Other Developments
17.1.9.3.4 Expansions
17.1.10 Eurofins Discovery
17.1.10.1 Business Overview
17.1.10.2 Products Offered
17.1.10.3 Recent Developments
17.1.10.3.1 Product Launches & Approvals
17.1.10.3.2 Deals
17.1.11 Benevolentai Limited
17.1.11.1 Business Overview
17.1.11.2 Products Offered
17.1.11.3 Recent Developments
17.1.11.3.1 Deals
17.1.12 Owkin
17.1.12.1 Business Overview
17.1.12.2 Products Offered
17.1.12.3 Recent Developments
17.1.12.3.1 Product Launches & Approvals
17.1.12.3.2 Deals
17.1.12.3.3 Other Developments
17.1.13 Pathai
17.1.13.1 Business Overview
17.1.13.2 Products Offered
17.1.13.3 Recent Developments
17.1.13.3.1 Product Launches & Approvals
17.1.13.3.2 Deals
17.1.14 Aidoc Medical Ltd.
17.1.14.1 Business Overview
17.1.14.2 Products Offered
17.1.14.3 Recent Developments
17.1.14.3.1 Product Launches & Approvals
17.1.14.3.2 Other Developments
17.1.15 Qure.AI
17.1.15.1 Business Overview
17.1.15.2 Products Offered
17.1.15.3 Recent Developments
17.1.15.3.1 Product Launches & Approvals
17.1.16 Deep Genomics
17.1.16.1 Business Overview
17.1.16.2 Products Offered
17.1.16.3 Recent Developments
17.1.16.3.1 Expansions
17.1.17 Sophia Genetics SA
17.1.17.1 Business Overview
17.1.17.2 Products Offered
17.1.17.3 Recent Developments
17.1.17.3.1 Product Launches & Enhancements
17.1.17.3.2 Deals
17.1.18 Unlearn.AI
17.1.18.1 Business Overview
17.1.18.2 Products Offered
17.1.18.3 Recent Developments
17.1.18.3.1 Deals
17.1.19 Verge Genomics
17.1.19.1 Business Overview
17.1.19.2 Products Offered
17.1.19.3 Recent Developments
17.1.19.3.1 Deals
17.2 Other Players
17.2.1 Synthio Labs Ltd
17.2.2 Bioptimus
17.2.3 Karyon Bio
17.2.4 Counterforce Health
17.2.5 Promise Bio

18.1 Research Approach
18.1.1 Secondary Research
18.1.1.1 Key Data From Secondary Sources
18.1.2 Primary Research
18.1.2.1 Primary Sources
18.1.2.2 Key Data From Primary Sources
18.1.2.3 Breakdown of Primary Interviews
18.1.2.4 Insights From Primary Experts
18.2 Research Methodology Design
18.3 Market Size Estimation
18.4 Data Triangulation
18.5 Research Assumptions
18.6 Research Limitations
18.6.1 Methodology-Related
18.6.2 Scope-Related
18.7 Risk Assessment

19.1 Discussion Guide
19.2 Knowledgestore: The Subscription Portal
19.3 Customization Options
19.4 Related Reports:
19.5 Author Details

• Nvidia Corporation
• Illumina, Inc.
• Tempus AI, Inc.
• Recursion
• Dassault Systèmes SE
• Schrödinger, Inc.
• Data4Cure, Inc.
• Microsoft Corporation
• Insilico Medicine
• Eurofins Discovery
• Benevolentai Limited
• Owkin
• Pathai
• Aidoc Medical Ltd.
• Qure.AI
• Deep Genomics
• Sophia Genetics SA
• Unlearn.AI
• Verge Genomics
• Synthio Labs Ltd
• Bioptimus
• Karyon Bio
• Counterforce Health
• Promise Bio

Table 1 Exchange Rates Utilized for Conversion to USD
Table 2 AI in Life Science Market: Porter’S Five Forces Analysis
Table 3 AI in Life Science Market: Role in Ecosystem
Table 4 Case 1: Generative AI Accelerates Drug Discovery, Clinical Research, and Operational Efficiency in Life Sciences
Table 5 Case 2: Johnson & Johnson Expands AI Integration Across Drug Discovery, Surgical Innovation, and Healthcare Operations
Table 6 Case 3: AI-Driven Drug Discovery and Clinical Optimization Accelerate Innovation in Life Sciences
Table 7 US Adjusted Reciprocal Tariff Rates
Table 8 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Jurisdiction Analysis of Top Applicant Countries for AI in Life Science Market
Table 14 AI in Life Science Market: Key Patents/Patent Applications
Table 15 Influence of Stakeholders on Buying Process of Top Three End Users (%)
Table 16 Key Buying Criteria for Top Three End Users
Table 17 Unmet Needs in AI in Life Science Market
Table 18 End User Expectations in AI in Life Science Market
Table 19 AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 20 AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 21 AI in Life Science Market for Machine Learning, by Region, 2024-2031 (USD Million)
Table 22 AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 23 AI in Life Science Market for Deep Learning, by Region, 2024-2031 (USD Million)
Table 24 AI in Life Science Market for Convolutional Neural Networks, by Region, 2024-2031 (USD Million)
Table 25 AI in Life Science Market for Recurrent Neural Networks, by Region, 2024-2031 (USD Million)
Table 26 AI in Life Science Market for Generative Adversarial Networks, by Region, 2024-2031 (USD Million)
Table 27 AI in Life Science Market for Graph Neural Networks, by Region, 2024-2031 (USD Million)
Table 28 AI in Life Science Market for Other Deep Learning Tools, by Region, 2024-2031 (USD Million)
Table 29 AI in Life Science Market for Supervised Learning, by Region, 2024-2031 (USD Million)
Table 30 AI in Life Science Market for Reinforcement Learning, by Region, 2024-2031 (USD Million)
Table 31 AI in Life Science Market for Unsupervised Learning, by Region, 2024-2031 (USD Million)
Table 32 AI in Life Science Market for Other Machine Learning Technologies, by Region, 2024-2031 (USD Million)
Table 33 AI in Life Science Market for Natural Language Processing, by Region, 2024-2031 (USD Million)
Table 34 AI in Life Science Market for Context-Aware Processing and Computing, by Region, 2024-2031 (USD Million)
Table 35 AI in Life Science Market for Computer Vision, by Region, 2024-2031 (USD Million)
Table 36 AI in Life Science Market for Image Analysis, by Region, 2024-2031 (USD Million)
Table 37 AI in Life Science Market for Other Tools, by Region, 2024-2031 (USD Million)
Table 38 AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 39 AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 40 AI in Life Science Market for Clinical Applications, by Region, 2024-2031 (USD Million)
Table 41 AI in Life Science Market for Drug Discovery, by Region, 2024-2031 (USD Million)
Table 42 AI in Life Science Market for Medical Imaging and Diagnostics, by Region, 2024-2031 (USD Million)
Table 43 AI in Life Science Market for Clinical Trials, by Region, 2024-2031 (USD Million)
Table 44 AI in Life Science Market for Precision Medicine, by Region, 2024-2031 (USD Million)
Table 45 AI in Life Science Market for Other Clinical Applications, by Region, 2024-2031 (USD Million)
Table 46 AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 47 AI in Life Science Market for Non-Clinical Applications, by Region, 2024-2031 (USD Million)
Table 48 AI in Life Science Market for R&D Support, by Region, 2024-2031 (USD Million)
Table 49 AI in Life Science Market for Data Analytics and Reporting, by Region, 2024-2031 (USD Million)
Table 50 AI in Life Science Market for Manufacturing & Quality Assurance, by Region, 2024-2031 (USD Million)
Table 51 AI in Life Science Market for Regulatory Affairs, by Region, 2024-2031 (USD Million)
Table 52 AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 53 AI in Life Science Market for Software, by Region, 2024-2031 (USD Million)
Table 54 AI in Life Science Market for Service, by Region, 2024-2031 (USD Million)
Table 55 AI in Life Science Market, by Deployment, 2024-2031 (USD Million)
Table 56 AI in Life Science Market for Cloud-Based Solutions, by Region, 2024-2031 (USD Million)
Table 57 AI in Life Science Market for on-Premise Solutions, by Region, 2024-2031 (USD Million)
Table 58 AI in Life Science Market for Hybrid Solutions, by Region, 2024-2031 (USD Million)
Table 59 AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 60 AI in Life Science Market for Cro & Cdmo, by Region, 2024-2031 (USD Million)
Table 61 AI in Life Science Market for Pharmaceutical Companies, by Region, 2024-2031 (USD Million)
Table 62 AI in Life Science Market for Biotechnology Companies, by Region, 2024-2031 (USD Million)
Table 63 AI in Life Science Market for Diagnostic Companies, by Region, 2024-2031 (USD Million)
Table 64 AI in Life Science Market for Academic and Government Laboratories, by Region, 2024-2031 (USD Million)
Table 65 AI in Life Science Market for Other End Users, by Region, 2024-2031 (USD Million)
Table 66 AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 67 AI in Life Science Market for End-to-End Solutions, by Region, 2024-2031 (USD Million)
Table 68 AI in Life Science Market for Niche/Point Solutions, by Region, 2024-2031 (USD Million)
Table 69 AI in Life Science Market for AI Technology, by Region, 2024-2031 (USD Million)
Table 70 AI in Life Science Market for Services, by Region, 2024-2031 (USD Million)
Table 71 AI in Life Science Market, by Region, 2024-2031 (USD Million)
Table 72 North America: AI in Life Science Market, by Country, 2024-2031 (USD Million)
Table 73 North America: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 74 North America: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 75 North America: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 76 North America: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 77 North America: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 78 North America: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 79 North America: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 80 North America: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 81 North America: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 82 North America: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 83 US: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 84 US: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 85 US: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 86 US: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 87 US: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 88 US: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 89 US: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 90 US: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 91 US: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 92 US: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 93 Canada: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 94 Canada: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 95 Canada: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 96 Canada: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 97 Canada: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 98 Canada: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 99 Canada: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 100 Canada: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 101 Canada: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 102 Canada: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 103 Europe: AI in Life Science Market, by Country, 2024-2031 (USD Million)
Table 104 Europe: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 105 Europe: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 106 Europe: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 107 Europe: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 108 Europe: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 109 Europe: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 110 Europe: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 111 Europe: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 112 Europe: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 113 Europe: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 114 Germany: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 115 Germany: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 116 Germany: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 117 Germany: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 118 Germany: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 119 Germany: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 120 Germany: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 121 Germany: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 122 Germany: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 123 Germany: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 124 France: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 125 France: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 126 France: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 127 France: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 128 France: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 129 France: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 130 France: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 131 France: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 132 France: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 133 France: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 134 UK: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 135 UK: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 136 UK: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 137 UK: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 138 UK: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 139 UK: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 140 UK: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 141 UK: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 142 UK: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 143 UK: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 144 Italy: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 145 Italy: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 146 Italy: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 147 Italy: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 148 Italy: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 149 Italy: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 150 Italy: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 151 Italy: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 152 Italy: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 153 Italy: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 154 Spain: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 155 Spain: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 156 Spain: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 157 Spain: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 158 Spain: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 159 Spain: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 160 Spain: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 161 Spain: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 162 Spain: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 163 Spain: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 164 Rest of Europe: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 165 Rest of Europe: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 166 Rest of Europe: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 167 Rest of Europe: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 168 Rest of Europe: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 169 Rest of Europe: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 170 Rest of Europe: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 171 Rest of Europe: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 172 Rest of Europe: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 173 Rest of Europe: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 174 Asia-Pacific: AI in Life Science Market, by Country, 2024-2031 (USD Million)
Table 175 Asia-Pacific: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 176 Asia-Pacific: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 177 Asia-Pacific: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 178 Asia-Pacific: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 179 Asia-Pacific: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 180 Asia-Pacific: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 181 Asia-Pacific: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 182 Asia-Pacific: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 183 Asia-Pacific: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 184 Asia-Pacific: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 185 China: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 186 China: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 187 China: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 188 China: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 189 China: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 190 China: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 191 China: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 192 China: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 193 China: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 194 China: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 195 Japan: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 196 Japan: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 197 Japan: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 198 Japan: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 199 Japan: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 200 Japan: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 201 Japan: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 202 Japan: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 203 Japan: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 204 Japan: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 205 India: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 206 India: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 207 India: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 208 India: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 209 India: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 210 India: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 211 India: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 212 India: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 213 India: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 214 India: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 215 Australia: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 216 Australia: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 217 Australia: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 218 Australia: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 219 Australia: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 220 Australia: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 221 Australia: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 222 Australia: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 223 Australia: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 224 Australia: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 225 South Korea: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 226 South Korea: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 227 South Korea: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 228 South Korea: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 229 South Korea: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 230 South Korea: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 231 South Korea: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 232 South Korea: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 233 South Korea: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 234 South Korea: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 235 Rest of Asia-Pacific: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 236 Rest of Asia-Pacific: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 237 Rest of Asia-Pacific: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 238 Rest of Asia-Pacific: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 239 Rest of Asia-Pacific: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 240 Rest of Asia-Pacific: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 241 Rest of Asia-Pacific: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 242 Rest of Asia-Pacific: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 243 Rest of Asia-Pacific: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 244 Rest of Asia-Pacific: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 245 Latin America: AI in Life Science Market, by Country, 2024-2031 (USD Million)
Table 246 Latin America: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 247 Latin America: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 248 Latin America: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 249 Latin America: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 250 Latin America: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 251 Latin America: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 252 Latin America: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 253 Latin America: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 254 Latin America: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 255 Latin America: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 256 Brazil: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 257 Brazil: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 258 Brazil: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 259 Brazil: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 260 Brazil: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 261 Brazil: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 262 Brazil: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 263 Brazil: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 264 Brazil: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 265 Brazil: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 266 Mexico: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 267 Mexico: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 268 Mexico: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 269 Mexico: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 270 Mexico: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 271 Mexico: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 272 Mexico: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 273 Mexico: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 274 Mexico: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 275 Mexico: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 276 Rest of Latin America: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 277 Rest of Latin America: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 278 Rest of Latin America: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 279 Rest of Latin America: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 280 Rest of Latin America: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 281 Rest of Latin America: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 282 Rest of Latin America: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 283 Rest of Latin America: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 284 Rest of Latin America: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 285 Rest of Latin America: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 286 Middle East & Africa: AI in Life Science Market, by Country, 2024-2031 (USD Million)
Table 287 Middle East & Africa: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 288 Middle East & Africa: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 289 Middle East & Africa: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 290 Middle East & Africa: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 291 Middle East & Africa: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 292 Middle East & Africa: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 293 Middle East & Africa: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 294 Middle East & Africa: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 295 Middle East & Africa: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 296 Middle East & Africa: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 297 GCC: AI in Life Science Market, by Country, 2024-2031 (USD Million)
Table 298 GCC: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 299 GCC: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 300 GCC: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 301 GCC: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 302 GCC: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 303 GCC: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 304 GCC: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 305 GCC: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 306 GCC: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 307 GCC: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 308 Saudi Arabia: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 309 Saudi Arabia: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 310 Saudi Arabia: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 311 Saudi Arabia: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 312 Saudi Arabia: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 313 Saudi Arabia: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 314 Saudi Arabia: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 315 Saudi Arabia: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 316 Saudi Arabia: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 317 Saudi Arabia: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 318 UAE: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 319 UAE: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 320 UAE: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 321 UAE: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 322 UAE: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 323 UAE: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 324 UAE: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 325 UAE: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 326 UAE: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 327 UAE: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 328 Rest of GCC: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 329 Rest of GCC: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 330 Rest of GCC: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 331 Rest of GCC: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 332 Rest of GCC: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 333 Rest of GCC: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 334 Rest of GCC: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 335 Rest of GCC: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 336 Rest of GCC: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 337 Rest of GCC: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 338 South Africa: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 339 South Africa: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 340 South Africa: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 341 South Africa: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 342 South Africa: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 343 South Africa: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 344 South Africa: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 345 South Africa: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 346 South Africa: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 347 South Africa: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 348 Rest of Middle East & Africa: AI in Life Science Market, by Offering, 2024-2031 (USD Million)
Table 349 Rest of Middle East & Africa: AI in Life Science Market, by Application, 2024-2031 (USD Million)
Table 350 Rest of Middle East & Africa: AI in Life Science Market for Clinical Applications, by Type, 2024-2031 (USD Million)
Table 351 Rest of Middle East & Africa: AI in Life Science Market for Non-Clinical Applications, by Type, 2024-2031 (USD Million)
Table 352 Rest of Middle East & Africa: AI in Life Science Market, by Component, 2024-2031 (USD Million)
Table 353 Rest of Middle East & Africa: AI in Life Science Market, by Tool, 2024-2031 (USD Million)
Table 354 Rest of Middle East & Africa: AI in Life Science Market for Machine Learning, by Type, 2024-2031 (USD Million)
Table 355 Rest of Middle East & Africa: AI in Life Science Market for Deep Learning, by Type, 2024-2031 (USD Million)
Table 356 Rest of Middle East & Africa: AI in Life Science Market, by Deployment Mode, 2024-2031 (USD Million)
Table 357 Rest of Middle East & Africa: AI in Life Science Market, by End User, 2024-2031 (USD Million)
Table 358 Overview of Strategies Adopted by Key Players in AI in Life Science Market, January 2023-April 2026
Table 359 AI in Life Science Market: Degree of Competition
Table 360 AI in Life Science Market: Region Footprint
Table 361 AI in Life Science Market: Offering Footprint
Table 362 AI in Life Science Market: Application Footprint
Table 363 AI in Life Science Market: End User Footprint
Table 364 AI in Life Science Market: Tools Footprint
Table 365 AI in Life Science Market: Detailed List of Key Startup/SME Players
Table 366 AI in Life Science Market: Competitive Benchmarking of Key Emerging Players/Startups, by Region
Table 367 AI in Life Science Market: Competitive Benchmarking of Key Emerging Players/Startups, by Offering
Table 368 AI in Life Science Market: Competitive Benchmarking of Key Emerging Players/Startups, by Application
Table 369 AI in Life Science Market: Solution Launches & Approvals, January 2023-April 2026
Table 370 AI in Life Science Market: Deals, January 2023-April 2026
Table 371 AI in Life Science Market: Expansions, January 2023-April 2026
Table 372 Nvidia Corporation: Company Overview
Table 373 Nvidia Corporation: Products /Solutions Offered
Table 374 Nvidia Corporation: Product Launches & Enhancements, January 2023-April 2026
Table 375 Nvidia Corporation: Deals, January 2023- April 2026
Table 376 Nvidia Corporation: Other Developments, January 2023-April 2026
Table 377 Illumina, Inc.: Company Overview
Table 378 Illumina, Inc.: Products /Solutions Offered
Table 379 Illumina, Inc.: Product Launches & Enhancements, January 2023-April 2026
Table 380 Illumina, Inc.: Deals, January 2023-April 2026
Table 381 Tempus AI, Inc.: Company Overview
Table 382 Tempus AI, Inc.: Products Offered
Table 383 Tempus AI, Inc.: Deals, January 2023-April 2026
Table 384 Tempus AI, Inc.: Other Developments, January 2023-April 2026
Table 385 Recursion: Company Overview
Table 386 Recursion: Products /Solutions Offered
Table 387 Recursion: Product Launches & Enhancements, January 2023-April 2026
Table 388 Recursion: Deals, January 2023- April 2026
Table 389 Recursion: Expansions, January 2023-April 2026
Table 390 Dassault Systèmes SE: Company Overview
Table 391 Dassault Systèmes SE: Products Offered
Table 392 Dassault Systèmes SE: Product Launches & Enhancements, January 2023-April 2026
Table 393 Dassault Systèmes SE: Deals, January 2023-April 2026
Table 394 Dassault Systèmes SE: Other Developments, January 2023-April 2026
Table 395 Schrödinger, Inc.: Company Overview
Table 396 Schrödinger, Inc.: Products /Solutions Offered
Table 397 Schrödinger, Inc.: Deals, January 2023-April 2026
Table 398 Schrödinger, Inc.: Other Developments, January 2023-April 2026
Table 399 Data4Cure, Inc.: Company Overview
Table 400 Data4Cure, Inc.: Products Offered
Table 401 Data4Cure, Inc.: Product Launches & Enhancements, January 2023-April 2026
Table 402 Data4Cure, Inc.: Other Developments, January 2023-April 2026
Table 403 Microsoft Corporation: Company Overview
Table 404 Microsoft Corporation: Products Offered
Table 405 Microsoft Corporation: Product Launches & Enhancements, January 2023-April 2026
Table 406 Microsoft Corporation: Deals, January 2023-April 2026
Table 407 Microsoft Corporation: Other Developments, January 2023-April 2026
Table 408 Insilico Medicine: Company Overview
Table 409 Insilico Medicine: Products /Services Offered
Table 410 Insilico Medicine: Product/Service Launches, January 2023-April 2026
Table 411 Insilico Medicine: Deals, January 2023-April 2026
Table 412 Insilico Medicine: Other Developments, January 2023-April 2026
Table 413 Insilico Medicine: Expansions, January 2023-April 2026
Table 414 Eurofins Discovery: Company Overview
Table 415 Eurofins Discovery: Products Offered
Table 416 Eurofins Discovery: Product Launches & Approvals, January 2023-April 2026
Table 417 Eurofins Discovery: Deals, January 2023-April 2026
Table 418 Benevolentai Limited: Company Overview
Table 419 Benevolentai Limited: Products Offered
Table 420 Benevolentai Limited: Deals, January 2023-April 2026
Table 421 Owkin: Company Overview
Table 422 Owkin: Products Offered
Table 423 Owkin: Product Launches & Approvals, January 2023-April 2026
Table 424 Owkin: Deals, January 2023-April 2026
Table 425 Owkin: Other Developments, January 2023-April 2026
Table 426 Pathai: Company Overview
Table 427 Pathai: Products Offered
Table 428 Pathai: Product Launches & Approvals, January 2023-April 2026
Table 429 Pathai: Deals, January 2023-April 2026
Table 430 Aidoc Medical Ltd.: Company Overview
Table 431 Aidoc Medical Ltd.: Products Offered
Table 432 Aidoc Medical Ltd.: Product Launches & Approvals, January 2023-April 2026
Table 433 Aidoc Medical Ltd.: Other Developments, January 2023-April 2026
Table 434 Qure.AI: Company Overview
Table 435 Qure.AI: Products Offered
Table 436 Qure.AI: Product Launches & Approvals, January 2023-April 2026
Table 437 Deep Genomics: Company Overview
Table 438 Deep Genomics: Products Offered
Table 439 Deep Genomics: Expansions, January 2023-April 2026
Table 440 Sophia Genetics SA: Company Overview
Table 441 Sophia Genetics SA: Products Offered
Table 442 Sophia Genetics SA: Product Launches & Enhancements, January 2023-April 2026
Table 443 Sophia Genetics SA: Deals, January 2023-April 2026
Table 444 Unlearn.AI: Company Overview
Table 445 Unlearn.AI: Products Offered
Table 446 Unlearn.AI: Deals, January 2023-April 2026
Table 447 Verge Genomics: Company Overview
Table 448 Verge Genomics: Products Offered
Table 449 Verge Genomics: Deals, January 2023-April 2026
Table 450 Synthio Labs Ltd.: Company Overview
Table 451 Bioptimus: Company Overview
Table 452 Karyon Bio: Company Overview
Table 453 Counterforce Health: Company Overview
Table 454 Promise Bio: Company Overview

Figure 1 Market Scenario
Figure 2 Global AI in Life Science Market, 2024-2031
Figure 3 Major Strategies Adopted by Key Players in AI in Life Science Market, 2023-2026
Figure 4 Disruptions Influencing Growth of AI in Life Science Market
Figure 5 High-Growth Segments in AI in Life Science Market, 2026-2031
Figure 6 Asia-Pacific to Register Highest Cagr in AI in Life Science Market During Forecast Period
Figure 7 Growing Adoption of Precision Medicine and AI in Drug Discovery to Drive Market
Figure 8 Clinical Applications in North America Accounted for Largest Market Share in 2025
Figure 9 Japan to Register Highest Growth Rate During Forecast Period
Figure 10 AI in Life Science Market: Drivers, Restraints, Opportunities, and Challenges
Figure 11 AI in Life Science Market: Porter’S Five Forces Analysis
Figure 12 AI in Life Science Market: Value Chain Analysis (2025)
Figure 13 AI in Life Science Market: Ecosystem Analysis
Figure 14 Trends/Disruptions Impacting Customers’ Businesses
Figure 15 Total Funding of Players in AI in Life Science Market
Figure 16 Jurisdiction and Top Applicant Analysis for AI in Life Science Market
Figure 17 Top Applicants & Owners (Companies/Institutions) for AI in Life Science Market (January 2015 to December 2025)
Figure 18 Influence of Stakeholders on Buying Process for End Users
Figure 19 Key Buying Criteria for Top Three End Users
Figure 20 North America: AI in Life Science Market Snapshot
Figure 21 Asia-Pacific: AI in Life Science Market Snapshot
Figure 22 Revenue Analysis of Key Players in AI in Life Science Market, 2021-2025 (USD Million)
Figure 23 AI in Life Science Market Share Analysis of Key Players (2025)
Figure 24 AI in Life Science Market: Company Evaluation Matrix (Key Players), 2025
Figure 25 AI in Life Science Market: Company Footprint
Figure 26 AI in Life Science Market: Company Evaluation Matrix (Startups/SMEs), 2025
Figure 27 Ev/EBITDA of Key Vendors
Figure 28 Year-to-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 29 AI in Life Science Market: Brand/Software Comparative Analysis
Figure 30 Nvidia Corporation: Company Snapshot (2025)
Figure 31 Illumina, Inc.: Company Snapshot (2025)
Figure 32 Tempus AI, Inc.: Company Snapshot (2025)
Figure 33 Recursion: Company Snapshot (2024)
Figure 34 Dassault Systèmes SE: Company Snapshot (2025)
Figure 35 Schrödinger, Inc.: Company Snapshot (2024)
Figure 36 Microsoft Corporation: Company Snapshot (2025)
Figure 37 Sophia Genetics SA: Company Snapshot (2025)
Figure 38 Research Design
Figure 39 Research Methodology: Hypothesis Building
Figure 40 Bottom-Up Approach
Figure 41 Top-Down Approach
Figure 42 Cagr Projections From Analysis of Market Drivers, Restraints, Opportunities, and Challenges
Figure 43 Cagr Projections: Supply-Side Analysis
Figure 44 Data Triangulation